97 related articles for article (PubMed ID: 21358717)
1. The novel antisense Bcl-2 inhibitor SPC2996 causes rapid leukemic cell clearance and immune activation in chronic lymphocytic leukemia.
Dürig J; Dührsen U; Klein-Hitpass L; Worm J; Hansen JB; Ørum H; Wissenbach M
Leukemia; 2011 Apr; 25(4):638-47. PubMed ID: 21358717
[TBL] [Abstract][Full Text] [Related]
2. Phase I to II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in patients with advanced chronic lymphocytic leukemia.
O'Brien SM; Cunningham CC; Golenkov AK; Turkina AG; Novick SC; Rai KR
J Clin Oncol; 2005 Oct; 23(30):7697-702. PubMed ID: 16186597
[TBL] [Abstract][Full Text] [Related]
3. Impaired up-regulation of polo-like kinase 2 in B-cell chronic lymphocytic leukaemia lymphocytes resistant to fludarabine and 2-chlorodeoxyadenosine: a potential marker of defective damage response.
de Viron E; Knoops L; Connerotte T; Smal C; Michaux L; Saussoy P; Vannuffel P; Beert E; Vekemans MC; Hermans C; Bontemps F; Van Den Neste E
Br J Haematol; 2009 Dec; 147(5):641-52. PubMed ID: 19764992
[TBL] [Abstract][Full Text] [Related]
4. Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia.
Panayiotidis P; Ganeshaguru K; Foroni L; Hoffbrand AV
Leukemia; 1995 Jul; 9(7):1227-32. PubMed ID: 7543175
[TBL] [Abstract][Full Text] [Related]
5. Thalidomide exerts distinct molecular antileukemic effects and combined thalidomide/fludarabine therapy is clinically effective in high-risk chronic lymphocytic leukemia.
Giannopoulos K; Dmoszynska A; Kowal M; Wasik-Szczepanek E; Bojarska-Junak A; Rolinski J; Döhner H; Stilgenbauer S; Bullinger L
Leukemia; 2009 Oct; 23(10):1771-8. PubMed ID: 19440214
[TBL] [Abstract][Full Text] [Related]
6. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.
Lagneaux L; Gillet N; Stamatopoulos B; Delforge A; Dejeneffe M; Massy M; Meuleman N; Kentos A; Martiat P; Willems L; Bron D
Exp Hematol; 2007 Oct; 35(10):1527-37. PubMed ID: 17697742
[TBL] [Abstract][Full Text] [Related]
7. Identification of progression markers in B-CLL by gene expression profiling.
Fält S; Merup M; Gahrton G; Lambert B; Wennborg A
Exp Hematol; 2005 Aug; 33(8):883-93. PubMed ID: 16038780
[TBL] [Abstract][Full Text] [Related]
8. Strong correlation between VEGF and MCL-1 mRNA expression levels in B-cell chronic lymphocytic leukemia.
Véronèse L; Tournilhac O; Verrelle P; Davi F; Dighiero G; Chautard E; Veyrat-Masson R; Kwiatkowski F; Goumy C; Gouas L; Bay JO; Vago P; Tchirkov A
Leuk Res; 2009 Dec; 33(12):1623-6. PubMed ID: 19487028
[TBL] [Abstract][Full Text] [Related]
9. CHR-2797: an antiproliferative aminopeptidase inhibitor that leads to amino acid deprivation in human leukemic cells.
Krige D; Needham LA; Bawden LJ; Flores N; Farmer H; Miles LE; Stone E; Callaghan J; Chandler S; Clark VL; Kirwin-Jones P; Legris V; Owen J; Patel T; Wood S; Box G; Laber D; Odedra R; Wright A; Wood LM; Eccles SA; Bone EA; Ayscough A; Drummond AH
Cancer Res; 2008 Aug; 68(16):6669-79. PubMed ID: 18701491
[TBL] [Abstract][Full Text] [Related]
10. Expression profiling of B cell chronic lymphocytic leukemia suggests deficient CD1-mediated immunity, polarized cytokine response, altered adhesion and increased intracellular protein transport and processing of leukemic cells.
Zheng Z; Venkatapathy S; Rao G; Harrington CA
Leukemia; 2002 Dec; 16(12):2429-37. PubMed ID: 12454749
[TBL] [Abstract][Full Text] [Related]
11. Bcl-2 family gene modulation during spontaneous apoptosis of B-chronic lymphocytic leukemia cells.
Sanz L; Garcia-Marco JA; Casanova B; de La Fuente MT; García-Gila M; Garcia-Pardo A; Silva A
Biochem Biophys Res Commun; 2004 Mar; 315(3):562-7. PubMed ID: 14975737
[TBL] [Abstract][Full Text] [Related]
12. Immunocytochemical detection of bcl-2 and p53 proteins in B-chronic lymphocytic leukemia patients.
Klobusická M; Kusenda J; Babusíková O
Neoplasma; 2002; 49(6):387-93. PubMed ID: 12584586
[TBL] [Abstract][Full Text] [Related]
13. Modulation of malignant B cell activation and apoptosis by bcl-2 antisense ODN and immunostimulatory CpG ODN.
Jahrsdörfer B; Jox R; Mühlenhoff L; Tschoep K; Krug A; Rothenfusser S; Meinhardt G; Emmerich B; Endres S; Hartmann G
J Leukoc Biol; 2002 Jul; 72(1):83-92. PubMed ID: 12101266
[TBL] [Abstract][Full Text] [Related]
14. Molecular heterogeneity in chronic lymphocytic leukemia is dependent on BCR signaling: clinical correlation.
Rodríguez A; Villuendas R; Yáñez L; Gómez ME; Díaz R; Pollán M; Hernández N; de la Cueva P; Marín MC; Swat A; Ruiz E; Cuadrado MA; Conde E; Lombardía L; Cifuentes F; Gonzalez M; García-Marco JA; Piris MA;
Leukemia; 2007 Sep; 21(9):1984-91. PubMed ID: 17611561
[TBL] [Abstract][Full Text] [Related]
15. ZAP-70 mRNA quantification in B-cell chronic lymphocytic leukaemia.
Catherwood MA; Matthews C; Niblock R; Dobbin E; Morris TC; Alexander HD
Eur J Haematol; 2006 Apr; 76(4):294-8. PubMed ID: 16519700
[TBL] [Abstract][Full Text] [Related]
16. Actinomycin D induces p53-independent cell death and prolongs survival in high-risk chronic lymphocytic leukemia.
Merkel O; Wacht N; Sifft E; Melchardt T; Hamacher F; Kocher T; Denk U; Hofbauer JP; Egle A; Scheideler M; Schlederer M; Steurer M; Kenner L; Greil R
Leukemia; 2012 Dec; 26(12):2508-16. PubMed ID: 22743622
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive study of TP53 mutations in chronic lymphocytic leukemia: Analysis of 1287 diagnostic and 1148 follow-up CLL samples.
Pekova S; Mazal O; Cmejla R; Hardekopf DW; Plachy R; Zejskova L; Haugvicova R; Jancuskova T; Karas M; Koza V; Smolej L; Bezdickova L; Kozak T
Leuk Res; 2011 Jul; 35(7):889-98. PubMed ID: 21232794
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemia.
Nakagawa Y; Yamaguchi S; Hasegawa M; Nemoto T; Inoue M; Suzuki K; Hirokawa K; Kitagawa M
Leuk Res; 2004 May; 28(5):487-94. PubMed ID: 15068902
[TBL] [Abstract][Full Text] [Related]
19. Expression profile of 11 proteins and their prognostic significance in patients with chronic lymphocytic leukemia (CLL).
Faderl S; Keating MJ; Do KA; Liang SY; Kantarjian HM; O'Brien S; Garcia-Manero G; Manshouri T; Albitar M
Leukemia; 2002 Jun; 16(6):1045-52. PubMed ID: 12040436
[TBL] [Abstract][Full Text] [Related]
20. Identification of gene expression signatures for molecular classification in human leukemia cells.
Song JH; Kim HJ; Lee CH; Kim SJ; Hwang SY; Kim TS
Int J Oncol; 2006 Jul; 29(1):57-64. PubMed ID: 16773185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]